ACE OncoCast

Targeting KRAS G12C Mutations

October 02, 2022 ACE Oncology Season 5 Episode 4
Targeting KRAS G12C Mutations
ACE OncoCast
More Info
ACE OncoCast
Targeting KRAS G12C Mutations
Oct 02, 2022 Season 5 Episode 4
ACE Oncology

In this episode, the experts assess the latest data on targeted therapy for KRAS G12C-mutated NSCLC, including the first phase III data on targeted therapy. Hear expert opinions of how these results may influence clinical practice.  

Show Notes

In this episode, the experts assess the latest data on targeted therapy for KRAS G12C-mutated NSCLC, including the first phase III data on targeted therapy. Hear expert opinions of how these results may influence clinical practice.